7 patents
Utility
Loxapine film oral dosage form
16 May 23
A loxapine film oral dosage form includes loxapine salt, free base, or prodrug in an amount effective to provide relief from acute agitation associated with schizophrenia or bipolar 1 disorder via oral transmucosal delivery, dispersed in a polymeric film forming system.
Mobarik Bilal, Rodolphe Obeid, Nadine Paiement
Filed: 2 Aug 18
Utility
Lipophilic active oral film formulation and method of making the same
14 Mar 23
Disclosed is a description and methods for formulating oral films containing lipophilic active ingredient(s), more particularly lipophilic active having a positive log P.
Carolin Madwar, Nadine Paiement, Rodolphe Obeid, Justin Conway, Erick Gonzalez-Labrada
Filed: 15 Apr 19
Utility
Oral film formulation for modulating absorption profile
18 Oct 22
An oral film dosage form includes a high viscosity polymer in an amount of from 1% to 5% by dry weight to reduce, modulate and/or control Cmax of an active agent.
Nadine Paiement, Rodolphe Obeid, Justin Conway, Billal Tir
Filed: 5 Oct 20
Utility
Film dosage form with extended release mucoadhesive particles
15 Jun 21
An orally administered dosage form that facilitates delivery of an agent locally in the buccal cavity for a sustained period of time includes mucoadhesive particles that are made of at least a mucoadhesive material combined with the agent, and which are dispersed in a disintegrating film.
Rodolphe Obeid, Nadine Paiement, Erick Gonzalez-Labrada
Filed: 23 Aug 18
Utility
Oral film formulation for modulating absorption profile
9 Nov 20
An oral film dosage form includes a high viscosity polymer in an amount of from 1% to 5% by dry weight to reduce, modulate and/or control Cmax of an active agent.
Nadine Paiement, Rodolphe Obeid, Justin W. Conway, Billal Tir
Filed: 27 Sep 18
Utility
Device and method of treating conditions associated with neuroinflammation
27 Jul 20
Disclosed is a device and method for treating a neurodegenerative disease or condition associated with neuroinflammation induced by a leukotriene.
Horst G. Zerbe, Rodolphe Obeid, Justin W. Conway, Nadine Paiement, Ludwig Aigner
Filed: 4 Mar 18
Utility
Solid oral film dosage forms and methods for making same
6 Apr 20
Oral film dosage forms that provide improved solubilization and stabilization of an active ingredient in particle form include at least one primary crystallization inhibitor in an amount that inhibits growth and/or agglomeration of the active ingredient, a polyoxyethylated fatty acid glycerides in an amount that further enhances inhibition of crystallization, growth and agglomeration of the particles of the pharmaceutically active ingredient; and at least one plasticizer present in an amount that is effective to increase flexibility and elasticity of the film dosage form.
Horst G. Zerbe, Nadine Paiement, Angela Angusti, Cormac Long, Rodolphe Obeid, Laetitia Rodes, Billal Tir
Filed: 6 Feb 17
- Prev
- 1
- Next
Patents are sorted by USPTO publication date, most recent first